VTRS Q4 2020 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$17B

Q4 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.6B+13.5% YoY

Gross Profit

$706M19.5% margin

Operating Income

-$881M-24.3% margin

Net Income

-$916M-25.3% margin

EPS (Diluted)

$-1.07

QoQ Revenue Growth

+21.9%

Cash Flow

Operating Cash Flow

$36M

Free Cash Flow

-$81M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$61.6B

Total Liabilities

$38.6B

Stockholders' Equity

$23.0B

Cash & Equivalents

$844M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.6B	$3.2B	+13.5%
Gross Profit	$706M	$1.1B	-35.0%
Operating Income	-$881M	$272M	-423.6%
Net Income	-$916M	$21M	-4567.3%